Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Cervical Cancer

Free Subscription 22.12.2025 1 Abdom Radiol (NY) 1 ACS Synth Biol 1 Acta Cytol 1 Acta Pharm 1 Adv Pharm Bull 1 Adv Sci (Weinh) 1 AJPM Focus 1 Ann Behav Med 1 Ann Ib Postgrad Med 1 Ann Ital Chir 1 Biomedica 1 BMC Cancer 1 BMC Health Serv Res 2 BMC Womens Health 2 BMJ Open 1 Cancer Rep (Hoboken) 1 Cell Death Dis 1 Chem Biol Drug Des 2 Clinics (Sao Paulo) 1 Comput Biol Med 1 Crit Rev Oncol Hematol 1 Eur J Med Res 1 Eur Radiol 1 FEBS J 2 Front Immunol 1 Front Oncol 1 Front Public Health 1 Ginekol Pol 1 Glob Epidemiol 1 Health Educ Res 1 Int J Afr Nurs Sci 3 Int J Cancer 2 Int J Gynecol Cancer 1 J Appl Clin Med Phys 1 J Commun Healthc 1 J Gen Intern Med 1 J Gynecol Oncol 6 J Low Genit Tract Dis 2 J Midlife Health 1 J Natl Cancer Inst 2 J Obstet Gynaecol Res 1 J Public Health Res 1 Medicine (Baltimore) 2 Mod Pathol 1 Mol Aspects Med 1 mSystems 2 Obstet Gynecol 1 Pak J Med Sci 2 PLoS One 1 Public Health 2 Radiother Oncol 1 Reprod Sci 1 Rev Colomb Obstet Ginecol 1 S Afr Fam Pract (2004) 1 Saudi Pharm J 4 Sci Rep 3 Tumour Virus Res 1 Womens Health (Lond) 1 Womens Health Issues 1 World J Surg Oncol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Abdom Radiol (NY)

1. DENG S, Liu L, Lin J, Xiong Z, et al
   Construction of a predictive model for radiation proctitis after radical radiotherapy for cervical cancer based on MRI radiomics.
   Abdom Radiol (NY). 2025 Dec 19. doi: 10.1007/s00261-025-05333.
   PubMed         Abstract available
   
   

   
   ACS Synth Biol

2. SINAN S, Kooistra RM, Rajaraman K, Islam Z, et al
   One-Pot Isothermal Linear Amplification and Cas12a-Based Nucleic Acid Detection.
   ACS Synth Biol. 2025;14:4714-4722.
   PubMed         Abstract available
   
   

   
   Acta Cytol

3. KOLONGOLO SS, Omondi T, Kutolo E, Guyah B, et al
   Cytomorphological Characteristics of Cervical Scrape from Controlled and Uncontrolled Diabetes Mellitus Patients Attending Tertiary Healthcare, Kenya.
   Acta Cytol. 2025;69:567-575.
   PubMed         Abstract available
   
   

   
   Acta Pharm

4. LE X, Chen Q, Cao S, Hu G, et al
   Pan-Cdk inhibitor ZK304709 suppresses Cdc20 expression and potentiates the anticancer activity of apcin in HeLa cervical cancer cells.
   Acta Pharm. 2025 Dec 17. doi: 10.2478/acph-2026-0002.
   PubMed         Abstract available
   
   

   
   Adv Pharm Bull

5. KHARI M, Jain N, Kaul S, Pandey M, et al
   siRNA and mRNA-Based Preventive and Therapeutic Strategies for HPV-Induced Cervical Cancer.
   Adv Pharm Bull. 2025;15:552-573.
   PubMed         Abstract available
   
   

   
   Adv Sci (Weinh)

6. GAO Y, Wen Q, Qiao S, Deng L, et al
   A Field-Deployable RotEx-LAMP-LFA Platform for Molecular Triage of HPV-Driven Oncogenesis.
   Adv Sci (Weinh). 2025;12:e09468.
   PubMed         Abstract available
   
   

   
   AJPM Focus

7. SALAZAR C, Walter E, Yang TY, Goel MS, et al
   Health-Related Social Needs and Cervical Cancer Screening in Alliance Chicago Community Health Centers.
   AJPM Focus. 2025;5:100439.
   PubMed         Abstract available
   
   

   
   Ann Behav Med

8. ASHING K, Blackman E, Song G, Gibbs D, et al
   Exploring quality of life impact on cancer screening in Black subgroups.
   Ann Behav Med. 2025;59:kaaf078.
   PubMed         Abstract available
   
   

   
   Ann Ib Postgrad Med

9. ABDUS-SALAM AA, Yusuf SA, Ehiedu ECG, Adeleke OK, et al
   HUMAN IMMUNODEFICIENCY VIRUS IN CERVICAL CANCER PATIENTS TREATED WITH RADIOTHERAPY IN IBADAN, NIGERIA; A REVISIT.
   Ann Ib Postgrad Med. 2025;23:83-87.
   PubMed         Abstract available
   
   

   
   Ann Ital Chir

10. BAI Y, Wu S, Zhang L
    Impact of Intraoperative Ultrasound-Guided Loop Electrosurgical Excision Procedure With Individualized Marking on Perioperative Stress Responses, Immune Parameters, and Clinical Outcomes: A Comparative Study With Conventional Surgery.
    Ann Ital Chir. 2025;96:1633-1640.
    PubMed         Abstract available
    
    

    
    Biomedica

11. MANZANO-CHAYA JS, Mendoza-Herrera T, Garcia-Ayala E
    [Uso de la inteligencia artificial en el diagnostico de alteraciones de la citologia cervicouterina: estudio observacional en poblacion universitaria].
    Biomedica. 2025;45.
    PubMed         Abstract available
    
    

    
    BMC Cancer

12. TESFAW A, Addissie A, Kantelhardt EJ, Getachew S, et al
    Survival status and predictors of mortality among patients with cervical cancer in two oncology units in Northwest Ethiopia: a retrospective follow-up study.
    BMC Cancer. 2025 Dec 17. doi: 10.1186/s12885-025-15444.
    PubMed        
    
    

    
    BMC Health Serv Res

13. GIANELLA C, Salmon-Mulanovich G, Bohorquez-Gutierrez J, Tapia P, et al
    Political determinants of cervical cancer control in Peru.
    BMC Health Serv Res. 2025;25:1605.
    PubMed         Abstract available
    
    

    
    BMC Womens Health

14. REMKES A, Zafinimampera A, Totofotsy O, Ratiaharison FE, et al
    Human papillomavirus awareness and vaccination willingness among adults in Madagascar: a cross-sectional study.
    BMC Womens Health. 2025;25:596.
    PubMed         Abstract available
    
    
15. OZMEN F, Ozata B, Erol B
    Evaluation of systemic inflammation- and nutrition-based indices in the prediction of HPV persistence.
    BMC Womens Health. 2025;25:598.
    PubMed         Abstract available
    
    

    
    BMJ Open

16. NAZRUL N, Rahman A, de Fouw M, Campbell C, et al
    Cervical high-risk human papillomavirus infection and its associated risk factors: a community-based cross-sectional study in hard-to-reach areas in Bangladesh.
    BMJ Open. 2025;15:e103915.
    PubMed         Abstract available
    
    
17. TESFAYE H, Mezmur H, Ahmed N, Tesfaye G, et al
    Human papillomavirus vaccine uptake and associated factors among in-school adolescent girls in Harari regional state, Eastern Ethiopia: a cross-sectional study.
    BMJ Open. 2025;15:e101727.
    PubMed         Abstract available
    
    

    
    Cancer Rep (Hoboken)

18. MASUM MHU, Parvin R, Heema HP, Akter A, et al
    Exploitation of Biocomputational Approaches for siRNA-Mediated Gene Silencing of HPV: A Novel Therapeutic Strategy for Cervical Cancer.
    Cancer Rep (Hoboken). 2025;8:e70434.
    PubMed         Abstract available
    
    

    
    Cell Death Dis

19. WANG H, Liu S, Li P, Zhang YS, et al
    PRDM1-driven SLC30A9 overexpression contributes to the malignant phenotype of cervical cancer cells via promoting mitochondrial hyperfunction.
    Cell Death Dis. 2025;16:895.
    PubMed         Abstract available
    
    

    
    Chem Biol Drug Des

20. HEGDE V, Bhat RM, Muddapur GV, Shettar AK, et al
    Discovery of Novel Oxadiazole-Triazole Hybrids as Lung and Cervical Cancer Agents: Synthesis, Docking, Biological Evaluation, and SAR Studies.
    Chem Biol Drug Des. 2025;106:e70225.
    PubMed         Abstract available
    
    

    
    Clinics (Sao Paulo)

21. WANG B, Zhu Y, Ru Z, Zhang Y, et al
    The role of SIGLEC9 in immunosuppression and prognosis in cervical cancer.
    Clinics (Sao Paulo). 2025;81:100849.
    PubMed         Abstract available
    
    
22. CASTANHEIRA CP, Lorenzi NPC, Chiarot FD, Cassenote AJF, et al
    Self-sampling for HPV genotyping: a study of vaginal and urine collection in Brazilian women with high-grade lesions.
    Clinics (Sao Paulo). 2025;80:100780.
    PubMed         Abstract available
    
    

    
    Comput Biol Med

23. DINAMANI SINGH S, Nagamani S
    Deciphering virus host interaction analysis to unravel core virus network signatures and computational drug repurposing for cervical cancer.
    Comput Biol Med. 2025;200:111395.
    PubMed         Abstract available
    
    

    
    Crit Rev Oncol Hematol

24. COSTA MT, Tavares V, Adega F, Medeiros R, et al
    Non-Coding RNAs and Liquid Biopsies: Emerging Biomarkers for Cervical Cancer.
    Crit Rev Oncol Hematol. 2025 Dec 16:105091.
    PubMed         Abstract available
    
    

    
    Eur J Med Res

25. WANG L, Wang L, Cao Y, Wang Q, et al
    A chemokine-based prognostic model featuring CXCL8, ITGA5, BACE2, CCR7, CERS4, and MEI1 for cervical cancer.
    Eur J Med Res. 2025 Dec 18. doi: 10.1186/s40001-025-03688.
    PubMed         Abstract available
    
    

    
    Eur Radiol

26. DOLCIAMI M, Criscione M, Bizzarri N, Amerighi A, et al
    Accuracy and clinical impact of MRI in early-stage cervical cancer after cervical conization, a retrospective study.
    Eur Radiol. 2025 Dec 18. doi: 10.1007/s00330-025-12178.
    PubMed         Abstract available
    
    

    
    FEBS J

27. SONG Y, Gui C, Xian Q, Lv N, et al
    Previously undescribed effects and mechanisms of STAT3 in HPV-induced DNA re-replication in response to DNA damage.
    FEBS J. 2025;292:6592-6607.
    PubMed         Abstract available
    
    

    
    Front Immunol

28. SUN L, Lang J, Wu X, Shi D, et al
    Complete remission of recurrent human papillomavirus-associated cervical cancer managed with camrelizumab and nanoparticle albumin-bound paclitaxel as second-line treatment: a case report.
    Front Immunol. 2025;16:1679950.
    PubMed         Abstract available
    
    
29. MA J, Zhu W, Zhao R, Shi Q, et al
    CD155-based chimeric antigen receptor T cells: a promising immunotherapy for cervical and breast cancer.
    Front Immunol. 2025;16:1631812.
    PubMed         Abstract available
    
    

    
    Front Oncol

30. BAI G, Chen F, Qiu J, Hua K, et al
    Machine learning-based prediction of clinical outcomes in cervical cancer using routine hematological indices: development and web implementation.
    Front Oncol. 2025;15:1661153.
    PubMed         Abstract available
    
    

    
    Front Public Health

31. BONNEY EY, Gyekye EF, Klutse J, Attoh DA, et al
    Barriers and facilitators of integrating cervical cancer screening into routine HIV care and acceptability of self-sampling for HPV DNA testing among people with HIV: an exploratory study in southern Ghana.
    Front Public Health. 2025;13:1679325.
    PubMed         Abstract available
    
    

    
    Ginekol Pol

32. KECZKOWSKA E, Zeber-Lubecka N, Szlendak-Sauer K, Nekanda-Trepka M, et al
    Colposcopy in pregnancy.
    Ginekol Pol. 2025;96:969-973.
    PubMed         Abstract available
    
    

    
    Glob Epidemiol

33. SINGH K, Grover A, Dhanasekaran K
    Cervical cancer burden in India: A descriptive epidemiological study and policy insights.
    Glob Epidemiol. 2025;10:100233.
    PubMed         Abstract available
    
    

    
    Health Educ Res

34. BAJINKA O, Touray M, Barrow A, Ouedraogo SY, et al
    Cancer education and capacity in sub-Saharan Africa-where do we stand?
    Health Educ Res. 2025;40:cyaf062.
    PubMed         Abstract available
    
    

    
    Int J Afr Nurs Sci

35. KWEHAYO P, Musaba MW, Oguttu F, Olowo S, et al
    Factors associated with utilization of cervical cancer screening services among women at a tertiary hospital in eastern Uganda: A cross sectional study.
    Int J Afr Nurs Sci. 2025;23:100897.
    PubMed         Abstract available
    
    

    
    Int J Cancer

36. TOTA JE, Shing JZ, Roberts JN, Anderson EM, et al
    Epidemiological approaches to evaluate clinical unmasking of HPV-associated cervical lesions in the HPV vaccination era.
    Int J Cancer. 2025 Sep 15. doi: 10.1002/ijc.70119.
    PubMed         Abstract available
    
    
37. PENG H, Li J, Zhou Q, Zhou H, et al
    Enhanced diagnostic accuracy of high-grade cervical intraepithelial neoplasia in postmenopausal women through PAX1/JAM3 methylation analysis.
    Int J Cancer. 2025 Nov 14. doi: 10.1002/ijc.70245.
    PubMed         Abstract available
    
    
38. VAHTERISTO M, Heinavaara S, Dillner J, Kalliala I, et al
    Long-term human papillomavirus genotype-specific risk of cervical high-grade intraepithelial lesion and cancer-By age group and triage cytology.
    Int J Cancer. 2026;158:931-941.
    PubMed         Abstract available
    
    

    
    Int J Gynecol Cancer

39. ZHOU J, Cai J, Li X, Liu C, et al
    Pelvic radiotherapy combined with immunotherapy and chemotherapy for stage IVB cervical cancer: a retrospective study.
    Int J Gynecol Cancer. 2025;36:102800.
    PubMed         Abstract available
    
    
40. MAYADEV JS, Albuquerque KV, Price JG, Marcrom S, et al
    ARTIA-Cervix: a prospective trial of adaptive radiation therapy for cervical cancer.
    Int J Gynecol Cancer. 2025 Nov 21:102823. doi: 10.1016/j.ijgc.2025.102823.
    PubMed         Abstract available
    
    

    
    J Appl Clin Med Phys

41. SEKMEN MI, Koca T, Cetmi DA, Bilek Y, et al
    Simultaneous integrated boost in locally advanced cervical cancer patients ineligible for brachytherapy: Dosimetric comparison of VMAT versus helical tomotherapy.
    J Appl Clin Med Phys. 2026;27:e70418.
    PubMed         Abstract available
    
    

    
    J Commun Healthc

42. GRIFFITHS G, Tomalty D, Adams MA, Giovannetti O, et al
    Assessing knowledge translation following a pre-cancer diagnosis: a multinational evaluation of online resources targeting patients with cervical dysplasia.
    J Commun Healthc. 2025;18:289-298.
    PubMed         Abstract available
    
    

    
    J Gen Intern Med

43. PRATT R, Bliss Barsness C, Lin J, Adan F, et al
    Experience with Cervical Cancer Screening and Views on HPV Self-Sampling Among Somali American Women.
    J Gen Intern Med. 2025 Dec 18. doi: 10.1007/s11606-025-10080.
    PubMed         Abstract available
    
    

    
    J Gynecol Oncol

44. RIGGENBACH E, Mose L, Imboden S, Siegenthaler F, et al
    Intensified radiochemotherapy with cisplatin and gemcitabine for cervical cancer in the modern era: a retrospective cohort study.
    J Gynecol Oncol. 2025 Dec 8. doi: 10.3802/jgo.2026.
    PubMed         Abstract available
    
    

    
    J Low Genit Tract Dis

45. BHATLA N, Shamsunder S, Zutshi V, Singh U, et al
    Resource-Based Good Clinical Practice Recommendations for Colposcopy Standards and Quality Assurance in Colposcopy Practice.
    J Low Genit Tract Dis. 2026;30:88-96.
    PubMed         Abstract available
    
    
46. MICHAAN N, Laskov I, Joubran J, Solomon N, et al
    Use of Virtual Reality for Pain Relief During Cervical Conization Under Local Anesthesia: A Randomized Controlled Trial.
    J Low Genit Tract Dis. 2026;30:43-47.
    PubMed         Abstract available
    
    
47. FINE JR, Bartel CM, Conde ST, Abdullah BA, et al
    Effects of Adherence to Colposcopy Guidelines on the Detection of Cervical Intraepithelial Neoplasia.
    J Low Genit Tract Dis. 2026;30:17-21.
    PubMed         Abstract available
    
    
48. CLARK C, Aquilina A, Perkins RB, Papagiannakis E, et al
    Automating the Detection of Acetowhite Lesions by Classifying the Temporal Behavior of Cervical Regions.
    J Low Genit Tract Dis. 2026;30:31-38.
    PubMed         Abstract available
    
    
49. CHODICK G, Adler L, Liran O, Mizrahi-Reuveni M, et al
    Follow-up of Women Testing Positive for Human Papillomavirus Non-16/18 With Normal Cytology in a Screening Context.
    J Low Genit Tract Dis. 2026;30:22-24.
    PubMed         Abstract available
    
    
50. HUANG S, Gentil LG, Schmidt C, Cullum R, et al
    Clinical Performance of HPV DNA and HPV RNA Assays for the Detection of High-Grade Cervical Lesions.
    J Low Genit Tract Dis. 2026;30:25-30.
    PubMed         Abstract available
    
    

    
    J Midlife Health

51. KUMARI S, Agrawal S, Nigam N, Singh N, et al
    Association between NAD (P) H: Quinone Oxidoreductase 1 C609T Gene Polymorphism and Risk Factors in Cases of Cervical Cancer in Indian Women.
    J Midlife Health. 2025;16:425-433.
    PubMed         Abstract available
    
    
52. SHRIVASTAVA SR, Bobhate PS, Pratidina KL
    Integrating Cervical Cancer Screening into Rural Healthcare Delivery Systems for Better Patient Outcomes.
    J Midlife Health. 2025;16:492-495.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

53. HATHAWAY CL, Hall M, de Bondt D, Broshkevitch CJ, et al
    The impact of HIV on cervical cancer elimination in Kwazulu-Natal: a comparative modeling analysis.
    J Natl Cancer Inst. 2025 Dec 18:djaf364. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Obstet Gynaecol Res

54. XUAN Y, Liu M, Gao L
    Letter to "Fertility-Sparing Trachelectomy With Sentinel Node Mapping in Early-Stage Cervical Cancer: Oncological Safety and Obstetric Outcomes From a Single-Institution Study".
    J Obstet Gynaecol Res. 2025;51:e70165.
    PubMed        
    
    
55. SAKAI A, Yahata H, Sugiura T, Nakahara K, et al
    Obstetric Outcome After Trachelectomy for Cervical Cancer Without Uterine Artery Preservation.
    J Obstet Gynaecol Res. 2025;51:e70170.
    PubMed         Abstract available
    
    

    
    J Public Health Res

56. MAYOUDOM TAGNE PJ, Ketchaji A, Kegha Ngodem VC, Moyo Tachoum JR, et al
    Cervical cancer screening and associated factors in women living with HIV followed at Bonassama District Hospital, Cameroon.
    J Public Health Res. 2025;14:22799036251401946.
    PubMed         Abstract available
    
    

    
    Medicine (Baltimore)

57. YE Y, Wang Y, Gong D, Zhao Y, et al
    Identification and experimental validation of copper metabolism-related genes in cervical cancer.
    Medicine (Baltimore). 2025;104:e46387.
    PubMed         Abstract available
    
    

    
    Mod Pathol

58. SUN Y, Smith C, Murray J, Zhu J, et al
    Comparative Analysis Reveals Recurrent Molecular Alterations in Low-Risk Human Papillomavirus 6 and Human Papillomavirus 11-Associated Squamous Cell Carcinoma of the Uterine Cervix and Vulva.
    Mod Pathol. 2025;38:100909.
    PubMed         Abstract available
    
    
59. XIE Q, Li J, Li J, Liu C, et al
    Spatial Evaluation and Prognostic Significance of V-Domain Immunoglobulin Suppressor of T-Cell Activation (VISTA) in Human Resectable Cervical Carcinoma: Implications for Immune Activation and Suppression.
    Mod Pathol. 2025;38:100851.
    PubMed         Abstract available
    
    

    
    Mol Aspects Med

60. HALL MT, Hyatt A, Smith MA, Torode J, et al
    Elimination of cervical cancer: the impact of HPV vaccination, primary HPV screening, and expanded access to cancer treatment services.
    Mol Aspects Med. 2025;107:101423.
    PubMed         Abstract available
    
    

    
    mSystems

61. DU H, Jiang X, Liu Y, Hou J, et al
    One-year restoration of vaginal health: synergistic dynamics of microbiome and metabolome following the elimination of high-grade cervical intraepithelial neoplasia.
    mSystems. 2025;10:e0119025.
    PubMed         Abstract available
    
    

    
    Obstet Gynecol

62. COVELLI VELEZ I, Youssef A, Li S, Gockley A, et al
    Decline in Rate of Radical Hysterectomies Performed by Gynecologic Oncologists in the United States.
    Obstet Gynecol. 2025 Sep 11. doi: 10.1097/AOG.0000000000006068.
    PubMed         Abstract available
    
    
63. JOURA E, Kjaer SK, Bautista O, Luxembourg A, et al
    Effect of Prior 9-Valent Human Papillomavirus Vaccination on Subsequent Lower Genital Tract Dysplasia After Cervical Excisional Surgery.
    Obstet Gynecol. 2026;147:73-82.
    PubMed         Abstract available
    
    

    
    Pak J Med Sci

64. JIANG F, Zhou P
    Prognostic significance of systemic immune inflammation index and systemic inflammation response index for cervical cancer: A systematic review and meta-analysis.
    Pak J Med Sci. 2025;41:3306-3315.
    PubMed         Abstract available
    
    

    
    PLoS One

65. YAN Z, Guo C, Liu Y, Li J, et al
    From cervix to multisite: Detection of lower genital tract lesions in a 10-year cross-sectional colposcopy clinic study.
    PLoS One. 2025;20:e0338489.
    PubMed         Abstract available
    
    
66. HOQUE R, Cirovic S, Hughes MP, Labeed FH, et al
    Electrophysiological fingerprints of healthy cervical epithelial and HeLa cells: Membrane potential, zeta potential and passive electrical properties.
    PLoS One. 2025;20:e0337538.
    PubMed         Abstract available
    
    

    
    Public Health

67. ERASO Y, Stefler D, Whitelock V, Clarke E, et al
    Women's initial preferences for self-sampling tests at home for cervical cancer screening in the UK: A mixed-methods analysis of demographic and behavioural factors.
    Public Health. 2025;251:106109.
    PubMed         Abstract available
    
    

    
    Radiother Oncol

68. XU B, Liu J, Fang M, Zhu H, et al
    Multicenter deep learning-based automatic delineation of CTV and PTV in uterine malignancy CT imaging.
    Radiother Oncol. 2026;214:111212.
    PubMed         Abstract available
    
    
69. GULSTENE S, Liu ZA, Milosevic M, Croke J, et al
    Pain control and opioid use as a function of workflow in MRI-guided interstitial cervix brachytherapy.
    Radiother Oncol. 2026;214:111239.
    PubMed         Abstract available
    
    

    
    Reprod Sci

70. LIU L, Zhao X
    Multilevel Transcriptomic Association Analysis Reveals Key Genes and Potential Mechanisms in Endometrial, Ovarian, and Cervical Cancers.
    Reprod Sci. 2025;32:3887-3898.
    PubMed         Abstract available
    
    

    
    Rev Colomb Obstet Ginecol

71. GARCIA-BALAGUERA C, Ruiz Rodriguez SP
    [Delays in the diagnosis and treatment of cervical cancer in the department of Meta, 2017-2023: a cross-sectional study].
    Rev Colomb Obstet Ginecol. 2025;76:4277.
    PubMed         Abstract available
    
    

    
    S Afr Fam Pract (2004)

72. TSHIRURUVHELA FM, Makhubu MJ, Marincowitz GJO, Marincowitz C, et al
    Factors contributing to delayed diagnosis of cervical cancer in human immunodeficiency virus-positive women.
    S Afr Fam Pract (2004). 2025;67:e1-e6.
    PubMed         Abstract available
    
    

    
    Saudi Pharm J

73. WANG J, Song G, Hussain L, Xing L, et al
    Deciphering the pharmacological mechanisms of salidroside in cervical cancer by combining network pharmacology, molecular docking, and in vitro studies.
    Saudi Pharm J. 2025;33:49.
    PubMed         Abstract available
    
    

    
    Sci Rep

74. AZZI A, Al-Dhelaan R, Al-Fahd A, Almukhalafi O, et al
    Assessment of awareness level among women about cervical smears, human papillomavirus (HPV), and HPV vaccine in Saudi Arabia.
    Sci Rep. 2025;15:44171.
    PubMed         Abstract available
    
    
75. WANG F, Liu Y, Wang L, Bai Y, et al
    Ginkgetin reverses cisplatin resistance in cervical cancer by regulating the Nrf2/HO-1 signaling pathway to induce ferroptosis.
    Sci Rep. 2025 Dec 17. doi: 10.1038/s41598-025-33111.
    PubMed         Abstract available
    
    
76. WEI H, Wang X, Wang Q, Lin B, et al
    Tie1 derived from cervical cancer promotes the invasion and metastasis by Ang1 mediating Tie2/PI3K/Akt signaling axis and angiogenesis.
    Sci Rep. 2025;15:43979.
    PubMed         Abstract available
    
    
77. KARAMI H, Soleimani-Jelodar R, Khezeli Z, Shoja Z, et al
    Exploring the association between the lineages of human papillomavirus type 16 and viral physical status in the development of cervical cancer in Iran.
    Sci Rep. 2025;15:43922.
    PubMed         Abstract available
    
    

    
    Tumour Virus Res

78. STRIKWERDA MA, Weerstand SA, Burchell GL, Tromp JM, et al
    The immunological heterogeneity of squamous cell carcinoma and adenocarcinoma of the uterine cervix: a systematic review.
    Tumour Virus Res. 2025;20:200323.
    PubMed         Abstract available
    
    
79. AWADALLA M, Al Rawi HZ, Alahmadi RM, Khojah OT, et al
    Transcriptomic profile of the immune genes, oncogenes, and tumor suppressor genes in HPV associated Cervical Intraepithelial Neoplasia 3 (CIN 3) and Cervical Squamous Cell Carcinoma (CSCC): Comparable expressions indicative of invasive potential.
    Tumour Virus Res. 2025;20:200327.
    PubMed         Abstract available
    
    
80. PARIDA P, Mukherjee N, Singh A, Lewis S, et al
    Precise identification of viral-host integration events in HPV-positive cervical cancers by targeted long-read sequencing.
    Tumour Virus Res. 2025;20:200325.
    PubMed         Abstract available
    
    

    
    Womens Health (Lond)

81. ABDULAI AM, Sisala IM, Issah I, Kyiu C, et al
    Knowledge, attitudes, and barriers to cervical cancer screening utilization among female healthcare professionals in the Tamale Metropolis.
    Womens Health (Lond). 2025;21:17455057251401319.
    PubMed         Abstract available
    
    

    
    Womens Health Issues

82. MAHONEY KM, Bravo L, McAllister A, Bogar K, et al
    Reproductive Health Services in Abortion-Providing Clinics: A Scoping Review of Provision and Policy Contexts.
    Womens Health Issues. 2025;35:424-441.
    PubMed         Abstract available
    
    

    
    World J Surg Oncol

83. MA Y, Shi S
    The impact of sequential chemoradiotherapy versus concurrent chemoradiotherapy on prognosis in adjuvant treatment after radical hysterectomy for cervical cancer.
    World J Surg Oncol. 2025 Dec 17. doi: 10.1186/s12957-025-04149.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.